Potency and in vivo recovery of high purity factor VIII concentrates
Mikaelsson, M.; Oswaldsson, U.; Nilsson, I.M.
Thrombosis and Haemostasis 72(1): 160-161
1994
ISSN/ISBN: 0340-6245 PMID: 7974366 Document Number: 427971
Document emailed within 1 workday
Related Documents
Kasper, C.K.; Kim, H.C.; Gomperts, E.D.; Smith, K.J.; Salzman, P.M.; Tipping, D.; Miller, R.; Montgomery, R.M. 1991: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates Thrombosis and Haemostasis 66(6): 730-733Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Smit Sibinga, C.T.; Daenen, S.M.; van Imhoff, G.W.; Maas, A.; Das, P.C. 1984: Heparin small pool high yield purified factor VIII: in vivo recovery and half-life of routinely produced freeze-dried concentrate Thrombosis and Haemostasis 51(1): 12-15
Sabin, C.; Pasi, J.; Phillips, A.; Elford, J.; Janossy, G.; Lee, C. 1994: CD4+ counts before and after switching to monoclonal high-purity factor VIIi concentrate in HIV-infected haemophilic patients Thrombosis and Haemostasis 72(2): 214-217
Orthner, C.L. 1984: Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography Journal of Laboratory and Clinical Medicine 104(5): 816-828
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Seghatchian, M.J.; Miller-Andersson, M. 1978: A colorimetric evaluation of factor VIII: C potency Medical Laboratory Sciences 35(4): 347-354
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B. 1982: Factor VIIi concentrates. Problems and protein chemistry characterization Die Medizinische Welt 33(28): 1027-1033
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Rodríguez Bueno, S.; Montoro Ronsano, J.B.; Martínez Sánchez, B.; Altisent Roca, C.; Tusell Puigvert, J.M. 1991: The administration of factor VIIi concentrates to hemophiliacs by continuous perfusion pump Medicina Clinica 96(10): 364-366
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Eich, S.; Kusch, M.; Grundmann, C.; Hanker, C.; Seitz, R.; König, H. 2003: Factor VIII determination in patient's plasma and concentrates: a novel test equally suited for both matrices Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(4): 347-353
Aznar, J.A.; Jorquera, J.I.; Peiró, A.; Garcia, I. 1984: The importance of corticoids added to continued treatment with Factor VIIi concentrates in the suppression of inhibitors in haemophilia a Thrombosis and Haemostasis 51(2): 217-221
Philippou, H.; Adami, A.; Lane, D.A.; MacGregor, I.R.; Tuddenham, E.G.; Lowe, G.D.; Rumley, A.; Ludlam, C.A. 1996: High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC Thrombosis and Haemostasis 76(1): 23-28